Benchmarking on PAP and Paracetamol Production in China
The consumption of paracetamol, which takes the most important position among NSAIDs, has kept growing worldwide, which promotes the production of PAP, the key raw material of paracetamol.
As one of main paracetamol manufacturers in the world, China's paracetamol export has constituted 30%-40% of the total paracetamol consumed in the world. On the other hand, process of PAP and paracetamol in China is improving, largely attributable to the governmental environmental protection policy.
However, China’s PAP manufacturers’ profit has been further squeezed by the growing investment in environmental protection and the global economic depression in 2008.
To further penetrate into the industry, especially the production process, CCM has produced a report of Benchmarking on PAP and Paracetamol Production in China, which will provide you with the answers to the following questions:
? What are the developing status and trends of the production processes of PAP and paracetamol in China?
? What are the production costs of these process by theoretical model?
? What are the actual production cost and total profit of benchmark enterprises of PAP and paracetamol in this report in China?
? How are the total profit comparison between benchmark enterprises of PAP and paracetamol?
?What are the financial analysis of benchmark enterprises in 2007?
? What are the prospective technologies of PAP production in China till 2015?
Liaoning Shixing Pharmaceutical & Chemical Co., Ltd.; Jiangsu Zhongming Pharm-Chemical Co., Ltd.; Anhui Bayi Chemical Industry Co., Ltd.; Shandong Anqiu Lu'an Pharmaceutical Co., Ltd.; Hebei Hengshui Jiheng (Group) Pharmacy Co., Ltd.
TABLE OF CONTENT
Executive summary
Introduction and methodologies
I Review of PAP & paracetamol industry
I-1 Brief introduction to paracetamol industry in China
I-2 Brief introduction to PAP industry in China
II Brief introduction to various technologies of PAP and paracetamol
II-1 Introduction to processes for PAP production
II-1.1 Industralized technologies of PAP in China
- Iron reduction of p-nitrophenol
- Catalytic hydrogenation of p-nitrophenol
- Catalytic hydrogenation of nitrobenzene
II-1.2 Technologies under research
- Electrolytic reduction of nitrobenzene
-Other findings
II-1.3 Comparison among the above four technologies
II-2 Introduction to processes for paracetamol production
II-2.1 One-step method
II-2.2 Two-step method
III Detailed introduction to most popular methods of PAP and paracetamol
III-1 Technology for PAP
III-1.1 Description of production process and theoretical model of raw materials by iron reduction technology
III-1.2 Description of production process and theoretical model of raw materials by nitrobenzene catalytic hydrogenation technology
III-2 Technology for paracetamol
III-2.1 Brief description of production process
III-2.2 Flow chart of paracetamol production
III-2.3 Theoretical model of raw materials
IV Estimation on cost and profit of PAP and paracetamol
IV-1 In PAP enterprises
IV-1.1 Jiangsu Zhongming (adopting PNCB technology)
- Basic situation in Jiangsu Zhongming
- Financial analysis of Jiangsu Zhongming in 2007
- Estimation on raw material cost
- Estimation on manufacturing cost
- Estimation on management cost
- Estimation on tatal production cost
- Estimation on profit
IV-1.2 Liaoning Tianbao (adopting PNCB technology)
-Basic situation in Liaoning Tianbao
-Financial analysis of Liaoning Tianbao in 2007
- Estimation on raw material cost
- Estimation on manufacturing cost
- Estimation on management cost
- Estimation on profit
IV-1.3 Liaoning Jinhua(adopting NB technology)
- Basic situation in Huludao Jinhu
- Estimation on raw material cost
- Estimation on manufacturing cost
- Estimation on management cost
- Estimation on profit
IV-1.4 Comparison among above three manufacturers
IV-2 In paracetamol enterprises
IV-2.1 Hebei Jiheng
-Basic situation in Hebei Jiheng
- Actual flowchart in Hebei Jiheng
-Financial analysis of Hebei Jiheng in 2007
- Estimation on raw material cost
- Estimation on manufacturing cost
- Estimation on management cost
- Estimation on total production cost
- Estimation on profit
IV-2.2 Lu’an Pharm
- Basic situation in Lu’an Pharm
- Financial analysis of Lu’an Pharm in 2007
- Estimation on raw material cost
- Estimation on manufacturing cost
- Estimation on management cost
- Estimation on total production cost
- Estimation on profit
IV-2.3 Comparison between Hebei Jiheng and Lu’an Pharm in profit
V Forecast on PAP & paracetamol industry in China
V-1 Forecast on market
V-2 Forecast on technology
V-3 Competitive power of Chinese paracetamol
VI Site Visit Reports
LIST OF TABLES
Table 1 Production situation of Chinese PAP producers, Nov-2008
Table 2 RMB/USD exchange rates, 1994-2008
Table I-1-1 Output of NSAIDs in China in 2007
Table I-1-2 Output, export, import and domestic consumption of paracetamol in China, 1998~2007
Table I-1-3 Average export price of Chinese paracetamol in 2007 and Jan-Aug. 2008
Table I-2-1 Export of Chinese PAP, 2000~2007
Table II-1-1 Major technologies of PAP production in China, 2008
Table II-1-2 Technologies adopted by overseas PAP producers
Table II-1-3 Production situation of Chinese PAP producers, Oct- 2008
Table II-1.2-1 Main patents on catalytic hydrogenation of nitrobenzene, 2004-2008
Table II-1.3 -1 Comparison among different technologies, Oct- 2008
Table II-2.3-1 Key researchers on paracetamol in China
Table III-1.1-1 Theoretical consumption of raw material of PAP in China, Oct- 2008
Table III-1.2-1 Theoretical consumption of raw material of PAP in China, Oct-2008
Table III-2.3-1 Theoretical estimation on raw material costs of paracetamol
Table IV-1.1-1 Main equipment in Jiangsu Zhongming
Table IV-1.1-2 General situation of Jiangsu Zhongming, Oct-2008
Table IV-1.1-3 Balance sheet of Jiangsu Zhongming in 2007
Table IV-1.1-4 Income statement of Jiangsu Zhongming in 2007
Table IV-1.1-5 Cash flow statement of Jiangsu Zhongming in 2007
Table IV-1.1-6 Financial analysis of Jiangsu Zhongming in 2007
Table IV-1.1-7 Raw material costs of PAP in Jiangsu Zhongming in Oct- 2008
Table IV-1.1-8 Estimation on manufacturing costs of PAP production in Jiangsu Zhongming, Oct-2008
Table IV-1.1-9 Estimation on management cost of Jiangsu Zhongming in Oct- 2008
Table IV-1.1-10 Estimation on total production costs in Jiangsu Zhongming, Oct-2008
Table IV-1.1-11 Tax ratio in China
Table IV-1.1-12 Estimation on profit of Jiangsu Zhongming, Oct-2008
Table IV-1.2-1 List of main sets of equipment in Liaoning Tianbao, Oct-2008
Table IV-1.2-2 General situation of Liaoning Tianbao
Table IV-1.2-3 Balance sheet of Liaoning Tianbao in 2007
Table IV-1.2-4 Income statement of Liaoning Tianbao in 2007
Table IV-1.2-5 Cash flow statement of Liaoning Tianbao in 2007
Table IV-1.2-6 Financial analysis of Liaoning Tianbao in 2007
Table IV-1.2-7 Raw material costs of PAP in Liaoning Tianbao in Oct-2008
Table IV-1.2-8 Estimation on manufacturing costs of PAP production in Liaoning Tianbao, Oct-2008
Table IV-1.2-9 Estimation on management cost of Jiangsu Zhongming, Oct-2008
Table IV-1.2-10 Estimation on profit of Liaoning Tianbao, Oct-2008
Table IV-1.3-1 Estimation on raw material cost of PAP in Liaoning Jinhua, Oct-2008
Table IV-1.3-2 Estimation on manufacturing costs of PAP production in Liaoning Jinhua, Oct-2008
Table IV-1.3-3 Estimation on management cost of Liaoning Jinhua, Oct-2008
Table IV-1.3-4 Estimation on profit of Liaoning Jinhua
Table IV-1.4-1 Comparison of cost between Jiangsu Zhongming and Liaoning Tianbao, Oct-2008
Table IV-1.4-2 Comparison of income and profit between Jiangsu Zhongming and Liaoning Tianbao, Oct-2008
Table IV-1.4-3 Comparison of cost and profit between Jiangsu Zhongming, Liaoning Tianbao and Liaoning Jinhua, Oct-2008
Table IV-2.1-1 Balance sheet of Hebei Jiheng in 2007
Table IV-2.1-2 Income statement of Hebei Jiheng in 2007
Table IV-2.1-3 Cash flow statement of Hebei Jiheng in 2007
Table IV-2.1-4 Financial analysis of Hebei Jiheng in 2007
Table IV-2.1-5 Estimation on raw material costs of paracetamol in Hebei Jiheng
Table IV-2.1-6 Manufacturing costs of paracetamol production in Hebei Jiheng
Table IV-2.1-7 Estimation on management cost of Hebei Jiheng
Table IV-2.1-8 Estimation of total production cost in Hebei Jiheng
Table IV-2.1-9 The profit estimation of paracetamol in Hebei Jiheng
Table IV-2.2-1 Balance sheet of Lu’an Pharm in 2007
Table IV-2.2-2 Income statement of Lu’an Pharm in 2007
Table IV-2.2-3 Cash flow statement of Lu’an Pharm in 2007
Table IV-2.2-4 Financial analysis of Lu’an Pharm in 2007
Table IV-2.2-5 Estimation on raw material costs of paracetamol in Lu’an Pharm
Table IV-2.2-6 Manufacturing costs of paracetamol production in Lu’an Pharm
Table IV-2.2-7 Estimation on management cost of Lu’an Pharm
Table IV-2.2-8 Estimation of total production cost in Lu’an Pharm
Table IV-2.2-9 The profit estimation of paracetamol in Lu’an Pharm
Table IV-2.3-1 Comparison between Hebei Jiheng and Lu’an Pharm in Oct 2008
Table V-2-1 Estimation on future technology structure of PAP in China, tonnes, 2008-2015
Table V-3-1 SWOT analysis of the top five paracetamol manufacturers in China
Table VI-1-1 List of main equipment of PAP production in Jiangsu Zhongming
Table VI-1-2 PAP specification in Jiangsu Zhongming
Table VI-2-1 List of main equipments in Liaoning Tianbao
Table VI-2-2 PAP specification in Liaoning Tianbao
Table VI-3-1 Equipments affiliated to 3,000 t/a PAP production line in Liaoning Tiancheng
LIST OF FIGURES
Figure1 Forecast on technology structure of PAP in China, 2008-2015
Figure I-1-1 Market share of main NSAIDs in China in 2007
Figure I-1-2 Export situation to different destinations of Chinese paracetamol, 2003~2007
Figure 1-1-3 Average export price of Chinese paracetamol, 1999~2007
Figure I-2-1 Output of PAP in China, 1998~2007
Figure I-2-2 Export volume and price of PAP produced by different process in China, 2000~2007
Figure I-2-3 Consumption structure of PAP in China, 2007
Figure V-2-1 Forecast on technology structure of PAP in China, 2008-2015, by output volume
Figure V-2-2 Forecast on technology structure of PAP in China, 2008-2015, by output share
